drugset / Trial / NCT00584870
RN624 In Adult Patients With Chronic Low Back Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate the analgesic efficacy of RN624 compared with placebo and compared with naproxen in the treatment of adult patients with chronic low back pain.
Timeline
- Start
- 2007-07-05
- Primary completion
- 2008-09-02
- Completion
- 2008-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | Oral |
| Subject | Tanezumab | Monoclonal antibody | 200 ug/kg | Intravenous |
Indications
No indication recorded.